Skip to content

Polaryx Therapeutics, Inc. PLYX Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

SBA Communications logo
SBA CommunicationsSBAC
$30M0.0%
DaVita logo
DaVitaDVA
5M0.0%
Wintrust Financial logo
Wintrust FinancialWTFC
20M0.0%
RBC Bearings logo
RBC BearingsRBC
10M0.0%
Citigroup logo
CitigroupC
30M0.0%
Kimberly-Clark logo
Kimberly-ClarkKMB
20M0.0%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$115.64M

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's convertible preferred stock authorized shares?
Polaryx Therapeutics, Inc. (PLYX) reported convertible preferred stock authorized shares of $40M in Q4 2025.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.